{"id":"https://openalex.org/W2387705388","doi":null,"title":"Controlled study of Venlafaxine-xr tablets and Fluoxetine in treatment of depression","display_name":"Controlled study of Venlafaxine-xr tablets and Fluoxetine in treatment of depression","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2387705388","mag":"2387705388"},"language":"en","primary_location":{"id":"mag:2387705388","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZMYX201015012.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764397312","display_name":"Medical Journal of Chinese People's Health","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361730560","host_organization_name":"China Association of Social Workers","host_organization_lineage":["https://openalex.org/P4361730560"],"host_organization_lineage_names":["China Association of Social Workers"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Medical Journal of Chinese People's Health","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084539561","display_name":"Ding Gai-feng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ding Gai-feng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5084539561"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.38334807,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9100000262260437},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9879999756813049},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8220000267028809},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.9049999713897705},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7850000262260437},{"id":"https://openalex.org/keywords/sustained-release-tablets","display_name":"sustained-release tablets","score":0.6010000109672546},{"id":"https://openalex.org/keywords/hamilton-depression-rating-scale","display_name":"Hamilton Depression Rating Scale","score":0.875},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.9303791522979736},{"id":"https://openalex.org/C2777198177","wikidata":"https://www.wikidata.org/wiki/Q3765927","display_name":"Hamd","level":3,"score":0.9275003671646118},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.8984253406524658},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6388236284255981},{"id":"https://openalex.org/C3018023364","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Significant difference","level":2,"score":0.5125732421875},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4952143728733063},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.47536128759384155},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.46642357110977173},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41823461651802063},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3628596365451813},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.16737741231918335},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.11044725775718689},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2387705388","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZMYX201015012.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764397312","display_name":"Medical Journal of Chinese People's Health","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361730560","host_organization_name":"China Association of Social Workers","host_organization_lineage":["https://openalex.org/P4361730560"],"host_organization_lineage_names":["China Association of Social Workers"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Medical Journal of Chinese People's Health","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2360542385","https://openalex.org/W2363678110","https://openalex.org/W2354287337","https://openalex.org/W2381980543","https://openalex.org/W2364965878","https://openalex.org/W2355958146","https://openalex.org/W2386464196","https://openalex.org/W2380797820","https://openalex.org/W2389199862","https://openalex.org/W2357543706"],"abstract_inverted_index":{"Objective:To":[0],"evaluate":[1],"the":[2,39,44,50,106],"efficacy":[3,35],"and":[4,24,30,41,43,56,122],"safety":[5],"of":[6,11,54,66,73,78,85,99,102,126],"venlafaxine'":[7],"xr":[8,119],"in":[9,124],"treatment":[10,125],"depression.Methods:60":[12],"cases":[13],"with":[14],"depression":[15],"were":[16,28,47],"divided":[17],"randomly":[18],"into":[19],"two":[20,96],"groups:":[21],"Venlafaxine(30":[22],"cases)":[23],"fluoxetine(30":[25],"cases).All":[26],"patients":[27],"treated":[29],"observed":[31],"within":[32,62],"8":[33,63],"weeks.The":[34,64],"was":[36],"evaluated":[37],"by":[38,49],"HAMD":[40,65,77],"CGI-BP":[42],"side":[45,100],"effects":[46,101],"assessed":[48],"TESS.Results:":[51],"The":[52],"score":[53],"venlafaxine":[55],"fluoxetine":[57],"group":[58,68,80,108],"are":[59,89,111],"significantly":[60],"declined":[61],"Venlafaxine":[67,103],"has":[69,81],"a(61.0\u00b114.0)":[70],"%":[71,83],"reduction":[72,84],"86.6%":[74],"total":[75,87],"efficiency;The":[76],"Fluoxetine":[79,107],"a(60.0\u00b112.5)":[82],"83.3%":[86],"efficiency.There":[88],"no":[90,112],"significant":[91,113],"statistical":[92,114],"difference(P0.05)":[93,115],"between":[94,116],"these":[95],"groups.The":[97],"rate":[98],"is":[104,109,120],"23.3%,and":[105],"26.6%.There":[110],"them.Conclusions:":[117],"Venlafaxine'":[118],"rapid,effective":[121],"safe":[123],"depression.":[127]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}